Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina DiPrimio

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Nature Biotechnology|December 29, 2009
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscleAravind Asokan, Julia C Conway, Jana L Phillips, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological NanoparticlesWuping Li, Aravind Asokan, Zhijian Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticlesWuping Li, Aravind Asokan, Zhijian Wu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Nature Biotechnology|December 29, 2009
Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscleAravind Asokan, Julia C Conway, Jana L Phillips, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological NanoparticlesWuping Li, Aravind Asokan, Zhijian Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticlesWuping Li, Aravind Asokan, Zhijian Wu, et al.
Pageof 2